Gracell Biotechnologies (GRCL) Short Interest Ratio & Short Volume → Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (From InvestorPlace) (Ad) Free GRCL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial Media Gracell Biotechnologies Short Interest DataCurrent Short Volume1,190,000 sharesPrevious Short Volume438,200 sharesChange Vs. Previous Month+171.57%Dollar Volume Sold Short$12.16 millionShort Interest Ratio / Days to Cover0.9Last Record DateJanuary 31, 2024Outstanding Shares72,678,000 sharesFloat Size72,660,000 sharesShort Percent of Float1.64%Today's Trading Volume0 sharesAverage Trading Volume1,315,803 sharesToday's Volume Vs. Average0% Short Selling Gracell Biotechnologies ? Sign up to receive the latest short interest report for Gracell Biotechnologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGRCL Short Interest Over TimeGRCL Days to Cover Over TimeGRCL Percentage of Float Shorted Over Time Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. Gracell Biotechnologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20241,190,000 shares $12.16 million +171.6%1.6%0.9 $10.22 1/15/2024438,200 shares $4.38 million -21.0%0.6%0.4 $10.00 12/31/2023554,400 shares $5.57 million -42.6%0.8%0.6 $10.04 12/15/2023965,800 shares $5.47 million -4.4%1.4%1.1 $5.66 11/30/20231,010,000 shares $4.92 million +9.5%1.4%2 $4.87 11/15/2023922,400 shares $4.21 million +2.6%1.3%2.1 $4.56 Get the Latest News and Ratings for GRCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gracell Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. 10/31/2023898,700 shares $3.02 million +7.9%1.1%2.2 $3.36 10/15/2023833,100 shares $2.02 million +1.0%1.0%2.3 $2.43 9/30/2023824,900 shares $2.38 million -10.6%1.0%2.6 $2.88 9/15/2023922,900 shares $2.98 million +3.8%1.1%4.2 $3.23 8/31/2023888,800 shares $2.92 million +11.2%1.2%2.7 $3.28 8/15/2023799,100 shares $3.17 million +6.8%1.0%2.4 $3.97 7/31/2023748,300 shares $2.82 million -24.8%1.3%2.2 $3.77 7/15/2023995,400 shares $4.88 million +4.9%1.8%3 $4.90 6/30/2023949,300 shares $3.62 million +192.5%1.7%3 $3.81 6/15/2023324,500 shares $1.90 million +20.9%0.6%1.2 $5.84 5/31/2023268,400 shares $735,416.00 -14.7%0.5%1.9 $2.74 5/15/2023314,600 shares $701,558.00 -15.5%0.6%3.1 $2.23 4/30/2023372,100 shares $647,454.00 -4.9%0.6%1.9 $1.74 4/15/2023391,200 shares $739,368.00 -9.2%0.7%1.2 $1.89 3/31/2023430,800 shares $801,288.00 +14.8%0.7%1.2 $1.86 3/15/2023375,400 shares $683,228.00 +10.0%0.6%1 $1.82 2/28/2023341,300 shares $686,013.00 +35.0%0.6%0.9 $2.01 2/15/2023252,800 shares $535,936.00 -14.8%0.4%0.6 $2.12 1/31/2023296,700 shares $637,905.00 +131.8%0.5%0.8 $2.15 1/15/2023128,000 shares $285,440.00 -23.2%0.2%1 $2.23 12/30/2022166,600 shares $383,180.00 -27.6%0.3%1.7 $2.30 12/15/2022230,200 shares $580,104.00 +49.0%0.4%2.5 $2.52 11/30/2022154,500 shares $502,125.00 -18.4%0.3%3.5 $3.25 11/15/2022189,300 shares $702,303.00 -41.7%0.3%4 $3.71 10/31/2022324,800 shares $1.04 million +31.1%0.6%5.9 $3.19 10/15/2022247,700 shares $745,577.00 -5.7%0.4%4.1 $3.01 9/30/2022262,600 shares $845,572.00 +29.8%0.5%4 $3.22 9/15/2022202,300 shares $445,060.00 -27.8%0.4%2.3 $2.20 8/31/2022280,200 shares $703,302.00 -7.3%0.5%3 $2.51 8/15/2022302,400 shares $1.02 million -53.0%0.5%2.7 $3.38 7/31/2022643,400 shares $2.27 million +2.6%1.1%5.3 $3.53 7/15/2022627,300 shares $2.57 million -46.8%1.1%5.2 $4.10 6/30/20221,180,000 shares $6.49 million +2.6%2.1%8.4 $5.50 6/15/20221,150,000 shares $4.27 million +43.4%2.0%6.4 $3.71Guard Against the Coming Financial Upheaval (Ad)America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.You can stream it for free right here. GRCL Short Interest - Frequently Asked Questions What is Gracell Biotechnologies' current short interest? Short interest is the volume of Gracell Biotechnologies shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 1,190,000 shares of GRCL short. 1.64% of Gracell Biotechnologies' shares are currently sold short. Learn More on Gracell Biotechnologies' current short interest. What is a good short interest ratio for Gracell Biotechnologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GRCL shares currently have a short interest ratio of 1.0. Learn More on Gracell Biotechnologies's short interest ratio. Which institutional investors are shorting Gracell Biotechnologies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Gracell Biotechnologies: Equitec Proprietary Markets LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Gracell Biotechnologies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.64% of Gracell Biotechnologies' floating shares are currently sold short. Is Gracell Biotechnologies' short interest increasing or decreasing? Gracell Biotechnologies saw a increase in short interest in January. As of January 31st, there was short interest totaling 1,190,000 shares, an increase of 171.6% from the previous total of 438,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Gracell Biotechnologies' float size? Gracell Biotechnologies currently has issued a total of 72,678,000 shares. Some of Gracell Biotechnologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Gracell Biotechnologies currently has a public float of 72,660,000 shares. How does Gracell Biotechnologies' short interest compare to its competitors? 1.64% of Gracell Biotechnologies' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Gracell Biotechnologies: SIGA Technologies, Inc. (13.53%), Arcturus Therapeutics Holdings Inc. (20.02%), Cogent Biosciences, Inc. (12.59%), PureTech Health plc (0.02%), Y-mAbs Therapeutics, Inc. (7.47%), Atrion Co. (8.86%), Aurinia Pharmaceuticals Inc. (8.11%), Pediatrix Medical Group, Inc. (5.60%), Disc Medicine, Inc. (12.97%), Savara Inc (6.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks. What does it mean to sell short Gracell Biotechnologies stock? Short selling GRCL is an investing strategy that aims to generate trading profit from Gracell Biotechnologies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gracell Biotechnologies? A short squeeze for Gracell Biotechnologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GRCL, which in turn drives the price of the stock up even further. How often is Gracell Biotechnologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRCL, twice per month. The most recent reporting period available is January, 31 2024. More Short Interest Resources from MarketBeat Related Companies: SIGA Technologies Short Interest Arcturus Therapeutics Short Interest Cogent Biosciences Short Interest PureTech Health Short Interest Y-mAbs Therapeutics Short Interest Atrion Short Interest Aurinia Pharmaceuticals Short Interest Pediatrix Medical Group Short Interest Disc Medicine Short Interest Savara Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GRCL) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOIC